Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Diabetologia|May 4, 2016
Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male miceSamira Alliouachene, Benoit Bilanges, Claire Chaussade, et al.
Biochemical and Biophysical Research Communications|November 26, 2009
Evidence for a role for the p110-alpha isoform of PI3K in skeletal functionAndrew Grey, Claire Chaussade, Victoria Empson, et al.
Blood|June 26, 2015
Essential role of class II PI3K-C2α in platelet membrane morphologyColin Valet, Gaëtan Chicanne, Childerick Severac, et al.
Bioorganic & Medicinal Chemistry|September 18, 2007
Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110alpha inhibitorsJackie D Kendall, Gordon W Rewcastle, Raphael Frederick, et al.
The Biochemical Journal|March 17, 2007
Evidence for functional redundancy of class IA PI3K isoforms in insulin signallingClaire Chaussade, Gordon W Rewcastle, Jackie D Kendall, et al.
Cell Reports|December 15, 2015
Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and SensitivitySamira Alliouachene, Benoit Bilanges, Gaëtan Chicanne, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2016
Novel pyrazolo[1,5-a]pyridines with improved aqueous solubility as p110α-selective PI3 kinase inhibitorsJackie D Kendall, Anna C Giddens, Kit Yee Tsang, et al.
Bioorganic & Medicinal Chemistry|December 20, 2011
Discovery of pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitorsJackie D Kendall, Patrick D O'Connor, Andrew J Marshall, et al.
Bioorganic & Medicinal Chemistry|December 20, 2011
Novel pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitors: Exploring the benzenesulfonohydrazide SARJackie D Kendall, Anna C Giddens, Kit Yee Tsang, et al.
Pageof 3